Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) showed up in the 13F filings of 1,342 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 9,075,153 | 26,884 | 0.30% | $7,004,838,346.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 8,741,270 | -95,904 | -1.09% | $6,747,123,706.00 |
| State Street Corp | 31 Dec, 2025 | 4,660,808 | -30,415 | -0.65% | $3,597,537,871.00 |
| DODGE & COX | 31 Dec, 2025 | 4,596,358 | 45,513 | 1.00% | $3,547,790,849.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 3,940,160 | -4,204,492 | -51.62% | $3,041,292,891.00 |
| Franklin Resources Inc | 31 Dec, 2025 | 2,560,004 | 106,861 | 4.36% | $1,975,990,279.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,519,540 | -16,358 | -0.65% | $1,936,711,198.00 |
| FMR LLC | 31 Dec, 2025 | 2,319,566 | 383,731 | 19.82% | $1,790,403,167.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 2,194,426 | 1,241,587 | 130.30% | $1,693,811,624.00 |
| Nuveen, LLC | 31 Dec, 2025 | 2,010,517 | 835,240 | 71.07% | $1,551,857,756.00 |
| LOOMIS SAYLES & CO L P | 31 Dec, 2025 | 1,934,326 | -45,127 | -2.28% | $1,493,048,247.00 |
| Invesco Ltd. | 31 Dec, 2025 | 1,591,105 | 106,632 | 7.18% | $1,228,126,594.00 |
| Capital World Investors | 31 Dec, 2025 | 1,398,003 | -600,363 | -30.04% | $1,079,077,052.00 |
| Morgan Stanley | 31 Dec, 2025 | 1,389,323 | -61,649 | -4.25% | $1,072,379,189.00 |
| NORGES BANK | 31 Dec, 2025 | 1,311,485 | 1,311,485 | 0.00% | $1,012,295,927.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 1,157,426 | -1,150,440 | -49.85% | $893,382,732.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 995,710 | 274,356 | 38.03% | $768,518,494.00 |
| Northern Trust Corp | 31 Dec, 2025 | 944,933 | -39,859 | -4.05% | $729,365,434.00 |
| Amundi | 31 Dec, 2025 | 791,906 | 170,165 | 27.37% | $611,248,483.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 778,001 | 22,436 | 2.97% | $600,515,632.00 |